Clinical Trial Update: Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial evaluating the effects of sapropterin on hepatic and systemic hemodynamics in patients with liver cirrhosis and portal hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Liver Cirrhosis, Portal Hypertension | Phase 2, Phase 3 | Status: COMPLETED